National Centre for Neuroimmunology and Emerging Diseases

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

The National Centre for Neuroimmunology and Emerging Disease (NCNED) is an Australian research group led by Sonya Marshall-Gradisnik and Donald Staines.[1]

The NCNED is a part of Griffith University Health, in south-east Queensland.

Potential biomarker[edit | edit source]

In February 2016 the research team led by Donald Staines and Sonya Marshall-Gradisnik announced it had created a diagnostic test for the disease using CD8 T cells.[2][3][4][5][6][7][8] The researchers have submitted patent claims in relation to their discovery.[9][10][11]

Professor Sonya Marshall-Gradisnik clarified that 'In response to a number of inquiries of this nature we are pleased to advise that we have both published papers, papers in press, and additional data not for publication, which constitutes commercial-in-confidence'.[12][13]

Notable studies[edit | edit source]

Funding[edit | edit source]

The NCNED is supported by the Queensland Government and philanthropic donors.[14]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]


The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history